Third-Party Risk Management refers to the process of identifying, assessing, and controlling potential risks associated with external parties involved in a clinical research project. These third parties may include contract research organizations, suppliers, vendors, or any other entities that provide services or resources to the study.
This management approach involves implementing strategies to mitigate risks that could impact the integrity, quality, or timeline of the research. It typically includes due diligence, ongoing monitoring, and establishing clear communication channels with third-party partners to ensure compliance with regulatory requirements and study protocols.
Third-Party Risk Management is crucial in clinical research because it helps maintain the integrity and reliability of study data. By effectively managing risks associated with external partners, researchers can ensure compliance with regulatory standards and protect the safety of study participants.
This approach is also important for maintaining the reputation of research institutions and sponsors. Proper risk management can prevent delays, cost overruns, and potential legal issues that may arise from inadequate oversight of third-party activities in clinical trials.
We’re pleased to announce a strategic partnership between Axcellant and Prometheus MedTech.AI — a medtech startup developing AI-powered solutions for…
The Axcellant team has returned from the European Association of Nuclear Medicine (EANM) Annual Congress in Barcelona — and it’s…
The robust development of nuclear medicine depends on the availability of radioactive isotopes, some of which are used for diagnostic…
Copyright @ 2026 Axcellant